Michael Milam in Sarasota, Florida

Medical School: University Of South Florida College Of Medicine
Graduation Year: 1984
The Primary Medical Specialty for Michael Milam is listed as: Infectious Disease
Approximate Years of Experience: 40
PAC (PECOS ID)#: 8426130071
NPI #: 1982701421
NPI Created On: 09/19/2006
NPI Last Updated Listed as: 10/14/2019
Primary Taxonomy Code: 207RI0200X
License Number:
ME0046769
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
4. New patient office or other outpatient visit, typically 45 minutes
5. New patient office or other outpatient visit, typically 60 minutes
6. New patient office or other outpatient visit, typically 60 minutes
7. Established patient office or other outpatient, visit typically 25 minutes
8. Established patient office or other outpatient, visit typically 40 minutes
9. Established patient office or other outpatient, visit typically 40 minutes
10. Initial hospital inpatient care, typically 70 minutes per day
11. Subsequent hospital inpatient care, typically 25 minutes per day
12. Subsequent hospital inpatient care, typically 35 minutes per day
13. Subsequent nursing facility visit, typically 25 minutes per day
14. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
15. Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
16. Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem
17. Injection, ceftriaxone sodium, per 250 mg
18. Injection, dalbavancin, 5 mg
19. Injection, daptomycin, 1 mg
20. Injection, ertapenem sodium, 500 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).